Categories AlphaGraphs, Earnings, Health Care
Key highlights from Abbott Laboratories (ABT) Q1 2024 earnings results
Abbott Laboratories (NYSE: ABT) reported its first quarter 2024 earnings results today.
Total sales increased 2.2% year-over-year to $10 billion. Organic sales growth was 10.8%.
Net earnings decreased 7% to $1.22 billion, or $0.70 per share, compared to last year. Adjusted EPS decreased 5% to $0.98.
Abbott expects GAAP EPS of $3.25-3.40 and adjusted EPS of $4.55-4.70 for full-year 2024. The company projects GAAP EPS of $0.69-0.73 and adjusted EPS of $1.08-1.12 for the second quarter of 2024.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Dropbox Q1 2025 adj. earnings rise 21%; revenue drops slightly
Dropbox, Inc. (NASDAQ: DBX) has reported an increase in adjusted earnings for the first quarter of 2025. Revenues decreased slightly during the three months. The tech firm, a leading cloud-based
Monster Beverage Corporation (MNST) Earnings: 1Q25 Key Numbers
Monster Beverage Corporation (NASDAQ: MNST) reported its earnings results for the first quarter of 2025. Reported net sales decreased 2.3% year-over-year to $1.85 billion. Net sales, excluding the Alcohol Brands
Infographic: How Expedia (EXPE) performed in Q1 2025
Expedia Group, Inc. (NASDAQ: EXPE) reported revenue of $2.9 billion for the first quarter of 2025, up 3% from the same period last year. Net loss attributable to Expedia Group,
